FACTOR V LEIDEN HETEROZYGOUS MUTATION

Clinical trials for FACTOR V LEIDEN HETEROZYGOUS MUTATION explained in plain language.

Never miss a new study

Get alerted when new FACTOR V LEIDEN HETEROZYGOUS MUTATION trials appear

Sign up with your email to follow new studies for FACTOR V LEIDEN HETEROZYGOUS MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

Study aims to perfect Post-Birth care for moms at risk of dangerous blood clots

Prevention Not yet recruiting

This study looks at how long women with a specific genetic risk factor should take blood thinners after giving birth to prevent dangerous clots. It will compare a shorter treatment (under 2 weeks) to a longer one (6 weeks) to see which is better at preventing clots and has fewer …

Matched conditions: FACTOR V LEIDEN HETEROZYGOUS MUTATION

Sponsor: Hospices Civils de Lyon • Aim: Prevention

Last updated Apr 03, 2026 14:43 UTC

FACTOR V LEIDEN HETEROZYGOUS MUTATION

Get alerted when new FACTOR V LEIDEN HETEROZYGOUS MUTATION trials appear

Study aims to perfect Post-Birth care for moms at risk of dangerous blood clots